Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics

26 Aug 2022

Abstract excerpt

Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators. Oncolytic viruses (OV) are an integral pillar of immuno-oncology and hold potential for not only delivering durable anti-tumor responses but also converting "cold" tumors to "hot" tumors. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36090051
DOI: 10.3389/fmolb.2022.930207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeuticsPMID 36090051Read ↗

Oncolytic Seneca Valley Virus: past perspectives and future directionsSemantic proximity Read ↗

Oncolytic Virotherapy: From Bench to BedsideSemantic proximity Read ↗

The oncolytic virus ΔPK has multimodal anti-tumor activity.Semantic proximity Read ↗

OvirusTdb: A database of oncolytic viruses for the advancement of therapeutics in cancerSemantic proximity Read ↗

Oncoviruses: How do they hijack their host and current treatment regimesSemantic proximity Read ↗

Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical DataSemantic proximity Read ↗

Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development DirectionsSemantic proximity Read ↗

Tumor Tropism of DNA Viruses for Oncolytic VirotherapySemantic proximity Read ↗

Evolution of Oncolytic Viruses: Novel Strategies for Cancer TreatmentSemantic proximity Read ↗

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusSemantic proximity Read ↗

Oncolytic virotherapy: the questions and the promiseSemantic proximity Read ↗

Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.